Insider Trading History of Noble James

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Noble James since 2007. The trader's CIK number is 1388000. At the time of the last reporting, Noble James was the Director of Adaptimmune Therapeutics Plc. (stock ticker symbol ADAP). Also see all insider trading activities at Adaptimmune Therapeutics Plc.

Note that in the past Noble James also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Adaptimmune Therapeutics Plc (ADAP) by Noble James

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 ADAP 0 $0 800,000 $6,016,000 0 $0
2019 ADAP 0 $0 0 $0 1,773,100 $253,553

Yearly summary of insider trading at Gw Pharmaceuticals Plc (GWPH) by Noble James

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 GWPH 0 $0 82,596 $1,269,004 82,596 $200,956

Yearly summary of insider trading at Curagen Corp (CRGN) by Noble James

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 CRGN 20,000 $57,400 0 $0 0 $0


Insider trading activities at 3 companies by Noble James:

1. Adaptimmune Therapeutics Plc (ADAP)

2. Gw Pharmaceuticals Plc (GWPH)

3. Curagen Corp (CRGN)

Table 1. Insider trading of Adaptimmune Therapeutics Plc (ADAP) by Noble James

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-05-29 ADAP Sale 500,000 9.33 4,666,000
2020-01-13 ADAP Sale 300,000 4.50 1,350,000
2019-05-16 ADAP Option Ex 1,773,100 .14 253,553

Table 2. Insider trading of Gw Pharmaceuticals Plc (GWPH) by Noble James

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-05-24 GWPH Sale 82,596 15.36 1,269,004
2019-05-24 GWPH Option Ex 82,596 2.43 200,956

Table 3. Insider trading of Curagen Corp (CRGN) by Noble James

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-05-08 CRGN Buy 20,000 2.87 57,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Noble James (Director of Adaptimmune Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.